Concepedia

Ashwini K. Banala

AK

Statistics

Publications

10

Citations

537

H-Index

10

Active since

2011

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

University of North Texas Health Science Center

Columbia University

University of North Texas

Ashwini K. Banala is an author at National Institute on Drug Abuse specializing in neuropharmacology, medicine, and pharmacology.

Publications per year

2011–2015

10

Publications

10

Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor

Amy Hauck Newman, Thijs Beuming, Ashwini K. Banala et al. · Journal of Medicinal Chemistry · 2012 · 179 citations · Full text

, , +17

A Single Glycine in Extracellular Loop 1 Is the Critical Determinant for Pharmacological Specificity of Dopamine D2 and D3 Receptors

Mayako Michino, Prashant Donthamsetti, Thijs Beuming et al. · Molecular Pharmacology · 2013 · 73 citations · Full text

, , +16

<i>N</i>-(3-Fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as Selective Dopamine D3 Receptor Ligands: Critical Role of the Carboxamide Linker for D3 Receptor Selectivity

Ashwini K. Banala, Benjamin Levy, Sameer S. Khatri et al. · Journal of Medicinal Chemistry · 2011 · 69 citations · Full text

, , +17

High Affinity Dopamine D<sub>3</sub>Receptor (D<sub>3</sub>R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D<sub>3</sub>R Knockout Mice

Comfort A. Boateng, Oluyomi M. Bakare, Jia Zhan et al. · Journal of Medicinal Chemistry · 2015 · 52 citations · Full text

, , +17

Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm

William S. John, Ashwini K. Banala, Amy Hauck Newman et al. · Psychopharmacology · 2014 · 41 citations · Full text

, , +17

1–5 of 10